Hoda Mahmoud Mohammad Abdulaziz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hoda Mahmoud Mohammad Abdulaziz has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Mohamed Naguib Attiya
Urology and Nephrology Center, Mansoura University , Mansoura
3 shared publicationsKarem Mohamed Salem
Department of Internal Medicine, Faculty of Medicine, Fayoum University , Fayoum
3 shared publicationsAhmed Mohammed Rashed Helal
Department of Internal Medicine, Faculty of Medicine, Fayoum University , Fayoum
2 shared publicationsMohammed Ghanem Gabr Mohammed
Nephrology Department, Theodor Bilharz Research Institute , Giza
2 shared publicationsNagy Sayed-Ahmed
Mansoura Nephrology and Dialysis Unit (MNDU), Department of Internal Medicine, Mansoura, Egypt
2 shared publicationsYusof Mohamed Omar
Faculty of Medicine, Mansoura University , Mansoura
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by MDPI AG in Kidney and Dialysis
- Vol. 6 (4) , 64
Evaluation of a WhatsApp-Based Multidisciplinary Cardiorenal Consultation Model for Hospitalized Patients
Background: Cardiorenal syndrome requires coordinated cardiology–nephrology management, but timely multidisciplinary input is often difficult to achieve in routine inpatient care. Smartphone-based messaging platforms such as WhatsApp are widely used informally by physicians, yet their structured use for inpatient cardiorenal teleconsultation has been scarcely evaluated. Methods: A single-center retrospective observational study of hospitalized adults with cardiorenal syndrome, discussed in a closed WhatsApp group that included consultant cardiologists, consultant nephrologists, and residents, between October 2023 and November 2025. Feasibility endpoints included response rate, response times, and degree of multidisciplinary participation. Clinical variables and management actions were extracted from chats and charts. Results: Of the 49 patient-related posts, 36 met the inclusion criteria for a complete analysis. The mean age was 58.5 ± 15.5 years, and 63.9% were male. The most prevalent cardiac diagnosis was pulmonary edema (30.6%), whereas acute kidney injury was the most prevalent kidney disease presentation (61.1%). More than 90% of teleconsultation posts received at least one consultant reply. Management actions among 34 answered posts included treatment modification in 24 patients, additional routine laboratory testing in 14, advanced investigations in 5, and specific interventions in 7. Conclusions: A WhatsApp-based multidisciplinary group achieved rapid and frequent consultant responses and subsequently requested management actions. Such doctor-to-doctor telenephrology models may augment existing cardiorenal services, provided that robust governance and data-protection frameworks are in place.
- 1 October 2026
- Published by MDPI AG in Kidney and Dialysis
- Vol. 6 (4) , 64
Open AccessEvaluation of a WhatsApp-Based Multidisciplinary Cardiorenal Consultation Model for Hospitalized Patients
Background: Cardiorenal syndrome requires coordinated cardiology–nephrology management, but timely multidisciplinary input is often difficult to achieve in routine inpatient care. Smartphone-based messaging platforms such as WhatsApp are widely used informally by physicians, yet their structured use for inpatient cardiorenal teleconsultation has been scarcely evaluated. Methods: A single-center retrospective observational study of hospitalized adults with cardiorenal syndrome, discussed in a closed WhatsApp group that included consultant cardiologists, consultant nephrologists, and residents, between October 2023 and November 2025. Feasibility endpoints included response rate, response times, and degree of multidisciplinary participation. Clinical variables and management actions were extracted from chats and charts. Results: Of the 49 patient-related posts, 36 met the inclusion criteria for a complete analysis. The mean age was 58.5 ± 15.5 years, and 63.9% were male. The most prevalent cardiac diagnosis was pulmonary edema (30.6%), whereas acute kidney injury was the most prevalent kidney disease presentation (61.1%). More than 90% of teleconsultation posts received at least one consultant reply. Management actions among 34 answered posts included treatment modification in 24 patients, additional routine laboratory testing in 14, advanced investigations in 5, and specific interventions in 7. Conclusions: A WhatsApp-based multidisciplinary group achieved rapid and frequent consultant responses and subsequently requested management actions. Such doctor-to-doctor telenephrology models may augment existing cardiorenal services, provided that robust governance and data-protection frameworks are in place.
- 26 May 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
Decoding hemodialysis patients' symptoms: navigating the complexity
Background: Hemodialysis (HD) patients frequently experience symptoms that negatively impact their quality of life. Besides individual symptoms, cluster symptoms and core symptoms are similarly important. Identifying these symptoms helps optimize patient care. This study was conducted to assess the various symptoms experienced by HD patients, their associated dimensions, factors, connections, and relationships. Methods: A cross-sectional study of 1156 patients undergoing HD in 27 centers across different regions in Egypt. Patients were approached through face-to-face interviews and patients' medical records were reviewd. Comorbidities were evaluated using a revised edition of the Charlson Comorbidity Index. The validated Arabic version of the Chronic Kidney Disease Symptom Burden Index (CKD-SBI) was applied to assess symptom burden. Network and principal component analyses were employed to identify core and cluster symptoms, respectively. Independent predictors of higher symptom burden were identified using logistic regression. Results: The median age of patients was 53 years. HD patients experienced an average of 9 symptoms with a median total symptom burden score of 14.01. Bone/joint pain was the most common individual symptom (62.9%), followed by feeling tired or lack of energy (57.4%), and muscle cramps (49.6%). Seven symptom clusters were identified. Feeling nervous and worrying were the core symptoms in the symptom network. Sex, residence, prior kidney transplantation, non-use of calcium channel blockers, functional status, Charlson Comorbidity Index, and hemoglobin level were independent predictors of symptom burden. Conclusion: Symptom burden among HD patients is complex, and rigorous measures are warranted to relieve these symptoms and improve patients' well-being.
- 26 May 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
Decoding hemodialysis patients' symptoms: navigating the complexity
Background: Hemodialysis (HD) patients frequently experience symptoms that negatively impact their quality of life. Besides individual symptoms, cluster symptoms and core symptoms are similarly important. Identifying these symptoms helps optimize patient care. This study was conducted to assess the various symptoms experienced by HD patients, their associated dimensions, factors, connections, and relationships. Methods: A cross-sectional study of 1156 patients undergoing HD in 27 centers across different regions in Egypt. Patients were approached through face-to-face interviews and patients' medical records were reviewd. Comorbidities were evaluated using a revised edition of the Charlson Comorbidity Index. The validated Arabic version of the Chronic Kidney Disease Symptom Burden Index (CKD-SBI) was applied to assess symptom burden. Network and principal component analyses were employed to identify core and cluster symptoms, respectively. Independent predictors of higher symptom burden were identified using logistic regression. Results: The median age of patients was 53 years. HD patients experienced an average of 9 symptoms with a median total symptom burden score of 14.01. Bone/joint pain was the most common individual symptom (62.9%), followed by feeling tired or lack of energy (57.4%), and muscle cramps (49.6%). Seven symptom clusters were identified. Feeling nervous and worrying were the core symptoms in the symptom network. Sex, residence, prior kidney transplantation, non-use of calcium channel blockers, functional status, Charlson Comorbidity Index, and hemoglobin level were independent predictors of symptom burden. Conclusion: Symptom burden among HD patients is complex, and rigorous measures are warranted to relieve these symptoms and improve patients' well-being.
- 22 January 2026
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 44 (4) , 629-635
Improvement of visit-to-visit SBP variability with lowering dialysate sodium concentration in patients undergoing hemodialysis: a randomized controlled trial
Background: Hypertension is considered a significant modifiable risk factor for cardiovascular disease among hemodialysis patients. Aside from blood pressure (BP) levels, blood pressure variability (BPV) has been independently associated with all-cause and cardiovascular mortality in hemodialysis patients. Sodium load is associated with thirst, fluid retention, interdialytic weight gain (IDWG), and hypertension. This study investigated the effect of lowering dialysate sodium concentration on visit-to-visit BPV in hemodialysis patients. Methods: Among 110 hemodialysis patients assessed for eligibility, 89 were randomized to receive hemodialysis either with standard dialysate sodium (143 mmol/l) or reduced dialysate sodium (140 mmol/l) for 3 months. Eighty-three patients completed the study. Predialysis BP readings were recorded with an automated device 2 weeks before and after the intervention. The visit-to-visit BPV was quantified at baseline and after 3 months by three metrics: the standard deviation (SD) of the BP, the coefficient of variation (CV), and the average real variability (ARV). Results: SD ( P = 0.02), CV ( P = 0.034), and ARV ( P < 0.001) of SBP were significantly decreased in the lower sodium dialysate group. No significant difference was observed between both groups in terms of diastolic BPV measures. Furthermore, IDWG was significantly decreased in the lowered sodium dialysate group after 3 months ( P = 0.02). Intradialytic adverse events were comparable for both groups. Conclusion: Lowering dialysate sodium concentration decreases visit-to-visit systolic BPV parameters and IDWG. Long-term studies are required to confirm postulated cardiovascular benefits. Trial registration: The trial was registered with ClinicalTrials.gov (trial registration number NCT05169125, trial registration date 23/12/2021).
- 22 January 2026
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 44 (4) , 629-635
Improvement of visit-to-visit SBP variability with lowering dialysate sodium concentration in patients undergoing hemodialysis: a randomized controlled trial
Background: Hypertension is considered a significant modifiable risk factor for cardiovascular disease among hemodialysis patients. Aside from blood pressure (BP) levels, blood pressure variability (BPV) has been independently associated with all-cause and cardiovascular mortality in hemodialysis patients. Sodium load is associated with thirst, fluid retention, interdialytic weight gain (IDWG), and hypertension. This study investigated the effect of lowering dialysate sodium concentration on visit-to-visit BPV in hemodialysis patients. Methods: Among 110 hemodialysis patients assessed for eligibility, 89 were randomized to receive hemodialysis either with standard dialysate sodium (143 mmol/l) or reduced dialysate sodium (140 mmol/l) for 3 months. Eighty-three patients completed the study. Predialysis BP readings were recorded with an automated device 2 weeks before and after the intervention. The visit-to-visit BPV was quantified at baseline and after 3 months by three metrics: the standard deviation (SD) of the BP, the coefficient of variation (CV), and the average real variability (ARV). Results: SD ( P = 0.02), CV ( P = 0.034), and ARV ( P < 0.001) of SBP were significantly decreased in the lower sodium dialysate group. No significant difference was observed between both groups in terms of diastolic BPV measures. Furthermore, IDWG was significantly decreased in the lowered sodium dialysate group after 3 months ( P = 0.02). Intradialytic adverse events were comparable for both groups. Conclusion: Lowering dialysate sodium concentration decreases visit-to-visit systolic BPV parameters and IDWG. Long-term studies are required to confirm postulated cardiovascular benefits. Trial registration: The trial was registered with ClinicalTrials.gov (trial registration number NCT05169125, trial registration date 23/12/2021).
- Open Access
- 9 July 2025
- Published by Wolters Kluwer Health in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 25 (3) , 117-125
Gait speed in nondialysis chronic kidney disease patients: role of peripheral neuropathy and cognitive impairment
Background: Peripheral neuropathy (PN) and cognitive impairment are common consequences of chronic kidney disease (CKD) and can lead to detrimental effects on gait. This study assessed the prevalence of PN and cognitive function decline and their impact on gait speed among CKD patients. Patients and methods: A cross-sectional study was conducted on 100 nondisabled adult CKD patients, who attended the nephrology outpatient clinic between June 2022 and March 2023. The total neuropathy score was used to evaluate the existence and severity of PN. The validated Arabic version of the Montreal Cognitive Assessment was used to evaluate global cognition through in-person interviews. For gait assessment, usual and maximal gait speeds were quantified over a 10-m walkway. Cognitive–motor interference was assessed by a walking-while-talking test over the same walkway. Results: The studied patients’ median age and estimated glomerular filtration rate were 54 years and 11.2 ml/min/1.73 m2, respectively. PN was highly prevalent (69%). Only age was a statistically significant independent predictor of neuropathy on multivariate analysis. For every additional year of age, the odds of exhibiting PN increase by 10.7% (95% confidence interval: 1.05–1.17). Cognitive impairment was detected in 32% of patients. Multiple linear regression adjusted for sex, diabetes, and BMI indicated that slower usual gait speed was independently associated with older age, higher total neuropathy score scores, and poorer cognitive function (P=0.028, P=0.019, and P<0.001, respectively). Conclusion: CKD is associated with impaired gait speed, possibly linked to PN severity and poor cognition. Early interventions might improve patient outcomes.
- 9 July 2025
- Published by Wolters Kluwer Health in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 25 (3) , 117-125
Open AccessGait speed in nondialysis chronic kidney disease patients: role of peripheral neuropathy and cognitive impairment
Background: Peripheral neuropathy (PN) and cognitive impairment are common consequences of chronic kidney disease (CKD) and can lead to detrimental effects on gait. This study assessed the prevalence of PN and cognitive function decline and their impact on gait speed among CKD patients. Patients and methods: A cross-sectional study was conducted on 100 nondisabled adult CKD patients, who attended the nephrology outpatient clinic between June 2022 and March 2023. The total neuropathy score was used to evaluate the existence and severity of PN. The validated Arabic version of the Montreal Cognitive Assessment was used to evaluate global cognition through in-person interviews. For gait assessment, usual and maximal gait speeds were quantified over a 10-m walkway. Cognitive–motor interference was assessed by a walking-while-talking test over the same walkway. Results: The studied patients’ median age and estimated glomerular filtration rate were 54 years and 11.2 ml/min/1.73 m2, respectively. PN was highly prevalent (69%). Only age was a statistically significant independent predictor of neuropathy on multivariate analysis. For every additional year of age, the odds of exhibiting PN increase by 10.7% (95% confidence interval: 1.05–1.17). Cognitive impairment was detected in 32% of patients. Multiple linear regression adjusted for sex, diabetes, and BMI indicated that slower usual gait speed was independently associated with older age, higher total neuropathy score scores, and poorer cognitive function (P=0.028, P=0.019, and P<0.001, respectively). Conclusion: CKD is associated with impaired gait speed, possibly linked to PN severity and poor cognition. Early interventions might improve patient outcomes.
- Open Access
- 2 July 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 34 (3) , 188-194
Exploring the Burden of Informal Caregiving for Patients Undergoing Long-term Hemodialysis: A Multicenter Study
Hemodialysis,caregiver burden,Zarit Burden Interview,informal caregiver
- 2 July 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 34 (3) , 188-194
Open AccessExploring the Burden of Informal Caregiving for Patients Undergoing Long-term Hemodialysis: A Multicenter Study
Hemodialysis,caregiver burden,Zarit Burden Interview,informal caregiver
- 14 March 2025
- Published by Wiley in Hemodialysis International
- Vol. 29 (3) , 310-318
Oral Sodium Bicarbonate vs. Use of Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis: A Randomized Controlled Trial
Introduction: The optimal strategy for correcting metabolic acidosis and maintaining acid–base balance in hemodialysis patients remains unclear. This study aimed to evaluate and compare the effects of oral bicarbonate administration vs. increased dialysate bicarbonate concentration on predialysis serum bicarbonate levels in hemodialysis patients with metabolic acidosis.Methods: This was a single‐center, open‐label, randomized controlled trial. Adult hemodialysis patients with metabolic acidosis (serum bicarbonate < 22 mmol/L) were randomly assigned in a 1:1:1 ratio to one of three treatment groups for 16 weeks: (1) standard dialysate (32 mM bicarbonate plus 3 mM acetate), (2) increased dialysate bicarbonate (34 mM bicarbonate plus 3 mM acetate), or (3) standard dialysate with daily oral sodium bicarbonate supplementation (0.3–0.5 mmol/kg). Of the 75 eligible participants, 66 completed the study. The primary outcome was the difference in predialysis serum bicarbonate levels between the groups at 16 weeks.Results: Baseline predialysis serum bicarbonate levels averaged approximately 19.5 mmol/L across all three groups. At 16 weeks, there was no statistically significant difference in predialysis serum bicarbonate levels among the groups (p = 0.701). The mean levels were 20.1 (SD 2.16) mmol/L in the standard dialysate group, 20.5 (SD 2.04) mmol/L in the increased dialysate bicarbonate group, and 20.8 (SD 2.61) mmol/L in the oral supplementation group. Compared to baseline, predialysis bicarbonate levels significantly increased within the increased dialysate bicarbonate group (p = 0.010) and the oral supplementation group (p = 0.021), but not in the control (standard dialysate, no oral supplementation) group.Conclusion: Oral or dialytic bicarbonate supplementation at the doses used in this study demonstrated equivalent effects on predialysis serum bicarbonate concentrations in acidotic hemodialysis patients. However, the amount of supplemental bicarbonate administered via either route was insufficient to achieve the target correction of acidosis (e.g., predialysis serum bicarbonate ≥ 22 mmol/L).
- 14 March 2025
- Published by Wiley in Hemodialysis International
- Vol. 29 (3) , 310-318
Oral Sodium Bicarbonate vs. Use of Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis: A Randomized Controlled Trial
Introduction: The optimal strategy for correcting metabolic acidosis and maintaining acid–base balance in hemodialysis patients remains unclear. This study aimed to evaluate and compare the effects of oral bicarbonate administration vs. increased dialysate bicarbonate concentration on predialysis serum bicarbonate levels in hemodialysis patients with metabolic acidosis.Methods: This was a single‐center, open‐label, randomized controlled trial. Adult hemodialysis patients with metabolic acidosis (serum bicarbonate < 22 mmol/L) were randomly assigned in a 1:1:1 ratio to one of three treatment groups for 16 weeks: (1) standard dialysate (32 mM bicarbonate plus 3 mM acetate), (2) increased dialysate bicarbonate (34 mM bicarbonate plus 3 mM acetate), or (3) standard dialysate with daily oral sodium bicarbonate supplementation (0.3–0.5 mmol/kg). Of the 75 eligible participants, 66 completed the study. The primary outcome was the difference in predialysis serum bicarbonate levels between the groups at 16 weeks.Results: Baseline predialysis serum bicarbonate levels averaged approximately 19.5 mmol/L across all three groups. At 16 weeks, there was no statistically significant difference in predialysis serum bicarbonate levels among the groups (p = 0.701). The mean levels were 20.1 (SD 2.16) mmol/L in the standard dialysate group, 20.5 (SD 2.04) mmol/L in the increased dialysate bicarbonate group, and 20.8 (SD 2.61) mmol/L in the oral supplementation group. Compared to baseline, predialysis bicarbonate levels significantly increased within the increased dialysate bicarbonate group (p = 0.010) and the oral supplementation group (p = 0.021), but not in the control (standard dialysate, no oral supplementation) group.Conclusion: Oral or dialytic bicarbonate supplementation at the doses used in this study demonstrated equivalent effects on predialysis serum bicarbonate concentrations in acidotic hemodialysis patients. However, the amount of supplemental bicarbonate administered via either route was insufficient to achieve the target correction of acidosis (e.g., predialysis serum bicarbonate ≥ 22 mmol/L).
- Open Access
- 8 January 2025
- Published by Wolters Kluwer Health in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 25 (1) , 29-34
Effect of Ramadan intermittent fasting on short-term heart rate variability among hemodialysis patients
Background: In the general population, prior research has demonstrated the positive effects of fasting on the heart, where it is linked to a reduction in the risk factors for cardiovascular disease. Although hemodialysis (HD) patients are considered very high risk, some patients are highly motivated and insist on fasting. Limited data exists on the effect of Ramadan fasting on heart rate variability (HRV) a measure of cardiac autonomic function among maintenance HD patients. Patients and methods: An observational longitudinal study of Ramadan fasting patients on maintenance HD. All participants underwent a 5 min Holter ECG recording at the end of the HD session during Ramadan 29 and 30, then another 5 min Holter ECG recording two months after Ramadan. Time and frequency domain HRV indices were analyzed. Results: Among 95 HD patients assessed for eligibility, 53 practiced Ramadan fasting either daily or intermittently. Forty-seven patients met inclusion and exclusion criteria and underwent 5 min Holter ECG recordings twice. The mean age of participants was 47.77 years (±13.78) and 59.6% were males. Patients did not differ significantly about heart rate, frequency, and time domain measures (P>0.05) during and two months after Ramadan. Conclusion: Practicing Ramadan intermittent fasting does not impose a substantial risk to the cardiac autonomic nervous system function among maintenance HD patients, further research is required to confirm these findings.
- 8 January 2025
- Published by Wolters Kluwer Health in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 25 (1) , 29-34
Open AccessEffect of Ramadan intermittent fasting on short-term heart rate variability among hemodialysis patients
Background: In the general population, prior research has demonstrated the positive effects of fasting on the heart, where it is linked to a reduction in the risk factors for cardiovascular disease. Although hemodialysis (HD) patients are considered very high risk, some patients are highly motivated and insist on fasting. Limited data exists on the effect of Ramadan fasting on heart rate variability (HRV) a measure of cardiac autonomic function among maintenance HD patients. Patients and methods: An observational longitudinal study of Ramadan fasting patients on maintenance HD. All participants underwent a 5 min Holter ECG recording at the end of the HD session during Ramadan 29 and 30, then another 5 min Holter ECG recording two months after Ramadan. Time and frequency domain HRV indices were analyzed. Results: Among 95 HD patients assessed for eligibility, 53 practiced Ramadan fasting either daily or intermittently. Forty-seven patients met inclusion and exclusion criteria and underwent 5 min Holter ECG recordings twice. The mean age of participants was 47.77 years (±13.78) and 59.6% were males. Patients did not differ significantly about heart rate, frequency, and time domain measures (P>0.05) during and two months after Ramadan. Conclusion: Practicing Ramadan intermittent fasting does not impose a substantial risk to the cardiac autonomic nervous system function among maintenance HD patients, further research is required to confirm these findings.
- Open Access
- 1 January 2025
- Published by Mansoura University in Mansoura Medical Journal
- Vol. 54 (1) , 1
Clinical Features and Prognosis of Acute Kidney Injury in Hospital-Admitted Patients with COVID-19 in Egypt: A Single-Center Experience
Background While COVID-19 primarily manifests clinically as a respiratory disease, it can also impact other organs, such as the kidneys. Acute kidney injury (AKI) is frequently seen in hospital-admitted patients with COVID-19 and is linked to poorer outcomes. This research sought to explore the rate, contributing elements, and consequences of AKI in individuals with COVID-19. Methods Data from 236 COVID-19-infected patients hospitalized at wards and intensive care units (ICUs) dedicated to isolation between September 2020 and February 2021 were analyzed. Comparisons between patients with and without AKI were done using statistical tests as appropriate. Binary logistic regression analyses were performed at the univariable and multivariable levels to identify AKI risk factors. Survival data based on AKI status was analyzed using the Kaplan-Meier curve. Results Overall, 81 (34.3%) of 236 participants experienced AKI during their hospitalization. Hospitalized COVID-19 individuals with age > 64 years, Favipiravir use, vasopressors use, pH ≤7.4, HCO3 ≤19.2, and blood glucose >212 mg/dl have 2.4-, 2.5-, 2.4-, 3.4-, 3.2-, 2.9-times higher odds to exhibit AKI. A significantly lower survival probability was found in individuals with AKI than in non-AKI (log-rank χ2(2) = 41.187, p < .001). A shorter median survival time for patients with AKI compared with those without was also noticed (8 days [95% CI 7.132–8.868] versus 12 days [95% CI 10.910-13.090]). Conclusion AKI is not uncommonly encountered in patients with COVID-19 in the course of their hospitalization and is linked to increased mortality.
- 1 January 2025
- Published by Mansoura University in Mansoura Medical Journal
- Vol. 54 (1) , 1
Open AccessClinical Features and Prognosis of Acute Kidney Injury in Hospital-Admitted Patients with COVID-19 in Egypt: A Single-Center Experience
Background While COVID-19 primarily manifests clinically as a respiratory disease, it can also impact other organs, such as the kidneys. Acute kidney injury (AKI) is frequently seen in hospital-admitted patients with COVID-19 and is linked to poorer outcomes. This research sought to explore the rate, contributing elements, and consequences of AKI in individuals with COVID-19. Methods Data from 236 COVID-19-infected patients hospitalized at wards and intensive care units (ICUs) dedicated to isolation between September 2020 and February 2021 were analyzed. Comparisons between patients with and without AKI were done using statistical tests as appropriate. Binary logistic regression analyses were performed at the univariable and multivariable levels to identify AKI risk factors. Survival data based on AKI status was analyzed using the Kaplan-Meier curve. Results Overall, 81 (34.3%) of 236 participants experienced AKI during their hospitalization. Hospitalized COVID-19 individuals with age > 64 years, Favipiravir use, vasopressors use, pH ≤7.4, HCO3 ≤19.2, and blood glucose >212 mg/dl have 2.4-, 2.5-, 2.4-, 3.4-, 3.2-, 2.9-times higher odds to exhibit AKI. A significantly lower survival probability was found in individuals with AKI than in non-AKI (log-rank χ2(2) = 41.187, p < .001). A shorter median survival time for patients with AKI compared with those without was also noticed (8 days [95% CI 7.132–8.868] versus 12 days [95% CI 10.910-13.090]). Conclusion AKI is not uncommonly encountered in patients with COVID-19 in the course of their hospitalization and is linked to increased mortality.
- Open Access
- 5 October 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 167, 115629
DPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney
- 5 October 2023
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 167, 115629
Open AccessDPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney
- 1 July 2023
- Published by Medknow in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 23 (3) , 90-98
Clinicopathologic features, chronic renal damage, and short-term outcomes of glomerular diseases in a middle east tertiary care center
Background: Glomerular diseases (GDs) place a significant burden on patients and health care systems, and they are a leading cause of end-stage renal disease (ESRD) globally. There is no national register for GDs in Egypt, and the outcomes of GDs are not extensively examined. As a result, studying GD patterns and outcomes, as well as the association between chronic renal injury at presentation and GD outcomes, was of great interest. Patients and methods: Patients with biopsy-proven GDs presenting to an Egyptian tertiary care center were enrolled and prospectively followed up for 6 months, until death or reaching ESRD. Chronic renal damage was assessed at diagnosis by calculating the total renal chronicity. Results: A total of 66 individuals with biopsy-confirmed GDs were enrolled in the study. Unexplained decrease in kidney function (62%), subnephrotic (23%), and nephrotic presentation (15%) were the most common reasons for a renal biopsy. The most common histological patterns were diffuse proliferative glomerulonephritis (GN), membranoproliferative GN, and sclerosing GN. Primary and secondary GDs made up 30.3 and 69.7% of the cases, respectively. At the end of the 6-month follow-up, 28 patients had recovered their renal function, 19 had advanced to ESRD, and seven had died. Hemoglobin level and the total renal chronicity score were the best ways to predict how well the kidneys would get better. Conclusion: In this tertiary care center Egyptian cohort, secondary GDs appeared to be more frequent than primary GDs, diffuse proliferative GN was the most common histopathological pattern, and rapid renal recovery was not the rule in this short period. The renal chronicity score could accurately predict the renal outcome.
- 1 July 2023
- Published by Medknow in Journal of The Egyptian Society of Nephrology and Transplantation
- Vol. 23 (3) , 90-98
Clinicopathologic features, chronic renal damage, and short-term outcomes of glomerular diseases in a middle east tertiary care center
Background: Glomerular diseases (GDs) place a significant burden on patients and health care systems, and they are a leading cause of end-stage renal disease (ESRD) globally. There is no national register for GDs in Egypt, and the outcomes of GDs are not extensively examined. As a result, studying GD patterns and outcomes, as well as the association between chronic renal injury at presentation and GD outcomes, was of great interest. Patients and methods: Patients with biopsy-proven GDs presenting to an Egyptian tertiary care center were enrolled and prospectively followed up for 6 months, until death or reaching ESRD. Chronic renal damage was assessed at diagnosis by calculating the total renal chronicity. Results: A total of 66 individuals with biopsy-confirmed GDs were enrolled in the study. Unexplained decrease in kidney function (62%), subnephrotic (23%), and nephrotic presentation (15%) were the most common reasons for a renal biopsy. The most common histological patterns were diffuse proliferative glomerulonephritis (GN), membranoproliferative GN, and sclerosing GN. Primary and secondary GDs made up 30.3 and 69.7% of the cases, respectively. At the end of the 6-month follow-up, 28 patients had recovered their renal function, 19 had advanced to ESRD, and seven had died. Hemoglobin level and the total renal chronicity score were the best ways to predict how well the kidneys would get better. Conclusion: In this tertiary care center Egyptian cohort, secondary GDs appeared to be more frequent than primary GDs, diffuse proliferative GN was the most common histopathological pattern, and rapid renal recovery was not the rule in this short period. The renal chronicity score could accurately predict the renal outcome.